TABLE 1.
Hib strains used in this study and their corresponding SBA titers obtained with quality control preparations
| Hib strain designation | SBA titer (50% killing) by antibody source
|
||
|---|---|---|---|
| Sandoglobulin | MPR | BPIG | |
| GB 3291a | 128 | 1,024 | 16,384 |
| DR 247 | 128 | 2,048 | 32,768 |
| DR 458b | 128 | 2,048 | 32,768 |
| DR 519 | 512 | 16,384 | 65,536 |
| DR 671 | 128 | 4,096 | 32,768 |
| DR 715 | 256 | 4,096 | 32,768 |
| DR 729 | 128 | 4,096 | 32,768 |
| DR 761 | 128 | 512 | 16,384 |
| DR 810 | 128 | 2,048 | 32,768 |
| Eagan S-2 mutantc | No titer | No titer | No titer |
Reference Hib strain (Centers for Disease Control and Prevention) used in the generation of Hib antiserum.
Hib strain from the Dominican Republic used in this study for the determination of SBA titers.
Unencapsulated mutant strain.